QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Selecting Risk Minimisation Measures in Practice under GVP Module XVI

Test your understanding of the concepts covered by GVP Module XVI: Selecting Risk Minimisation Measures in Practice.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What is the main concern with adding complex controls to a risk already adequately managed by routine measures?

Additional measures can create burden, workarounds and reduced attention to important controls Routine measures cannot legally coexist with additional measures Complex controls always increase inappropriate exposure Additional measures prevent any future update to the RMP

Question 2 of 10 When an RMM appears not to work, what is the most appropriate first response?

Automatically issue another educational document Immediately impose the most restrictive available control Identify where the pathway failed, such as reach, comprehension, feasibility or targeting Stop all routine risk-minimisation measures

Question 3 of 10 An educational guide reaches 95% of target prescribers, but appropriate monitoring does not improve. What is the most appropriate interpretation?

The RMM is effective because distribution exceeded 90% The RMM is ineffective solely because the adverse reaction rate is unknown Implementation reach is demonstrated, but the targeted behavioural effect has not been demonstrated The guide should automatically be replaced by a restricted-distribution programme

Question 4 of 10 Why should a risk-control programme be assessed as a process rather than merely as a collection of documents?

Documents are never relevant to risk minimisation The programme must control defined steps in the prescribing, supply or treatment pathway and assign responsibility for them Multiple documents automatically demonstrate effectiveness Process assessment is needed only when the medicine is supplied in hospitals

Question 5 of 10 What is the correct relationship between routine and additional risk minimisation?

Additional measures should replace product information whenever a serious risk exists Routine measures are the baseline, and additional measures require justification based on residual risk Additional measures are preferred whenever they are more visible to stakeholders Routine measures are relevant only for risks that are not preventable

Question 6 of 10 A checklist is proposed for a risk that depends on completing several laboratory and contraindication checks before prescribing. Under which condition is the checklist most likely to be useful?

It is available at the point of prescribing and is understood and used It is distributed once, regardless of whether prescribers use it It contains every possible safety topic for the medicine It is kept centrally but not integrated into the prescribing workflow

Question 7 of 10 Why is version control of risk-minimisation materials a patient-safety issue?

It ensures that users can distinguish current approved information from obsolete content It allows materials to contain promotional information after approval It removes the need to monitor national implementation It guarantees that recipients have understood the material

Question 8 of 10 Which statement best distinguishes a safety communication from an RMM?

Every safety communication is automatically an additional RMM An RMM is distinguished by its defined purpose as an intervention intended to reduce a particular risk Safety communications never contain required actions RMMs cannot use communications as intervention tools

Question 9 of 10 A company finds that an RMM was implemented correctly, the targeted behaviour changed, but the clinical outcome did not improve. Which conclusion is most defensible?

The RMM is definitively successful because behaviour changed The RMM is definitively ineffective because the outcome did not change The organisation should reassess whether the intervention mechanism or underlying risk hypothesis adequately explains the outcome The implementation data should be discarded because clinical outcomes are the only valid evidence

Question 10 of 10 What is the most appropriate role for QPPV oversight of significant RMM issues?

Personally approve every educational material regardless of significance Remain uninvolved because RMMs belong exclusively to regulatory affairs Maintain sufficient visibility to challenge inadequate rationale, implementation, escalation or effectiveness evaluation Replace the MAH's operational governance processes

Knowledge Assessment: Selecting Risk Minimisation Measures in Practice under GVP Module XVI

Cookie Settings